Transcription of Annex 4 - WHO
{{id}} {{{paragraph}}}
Example: bachelor of science
Annex 4 - WHO
189 Annex 4 Recommendations to assure the quality, safety and efficacy of recombinant hepatitis B vaccinesReplacement of Annex 2 of WHO Technical Report Series, No. 786 and Annex 4 of WHO Technical Report Series, No. 889 Abbreviations 1911. Introduction 1912. General considerations 192 Part A. Manufacturing recommendations Definitions General manufacturing recommendations Control of source materials Fermentation Single harvests Control of aqueous bulk (purified antigen bulk) Final vaccine bulk Filling and containers Control tests on the final vaccine lot Records Retained samples Labelling Distribution and shipping Stability testing, storage and expiry date 207 Part B.
Annex 4 193 HBsAg made by recombinant DNA methods. It is expected that new or significantly modified recombinant hepatitis B vaccine formulations will be
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: